Pericarditis clinical trials at UCLA

1 research study open to eligible people

Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
open to eligible people ages 18-80
This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
Santa Monica, California and other locations

Last updated: August 25, 2026